Yesterday's business news made me terribly sad, but also admittedly happy.
You see, I have a child with Down Syndrome (DS) and I'm glad my wife and I didn't know beforehand. We had the typical amount of prenatal testing and nothing serious was found. Now this new test from Sequenom may dramatically reduce the number of children born with DS. In the abstract I think this would be great. But I also think it will negatively affect the prospects for people who already have DS. As the population of people with DS declines so will the potential ROI on any new drugs/treatments. Am I being unduly negative here?